United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 12, 2026 · Filed Oct 13, 2026

On Oct 12, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$550.70 for US$5.23M under a trading plan, leaving 324,443 shares. Filed Oct 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$550.70 average (US$548.13 to US$554.46)
Value
US$5.23M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 12, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 12, 2026Common StockSale428US$548.13333,515Indirect
Oct 12, 2026Common StockSale1,329US$549.01332,186Indirect
Oct 12, 2026Common StockSale2,565US$550.03329,621Indirect
Oct 12, 2026Common StockSale2,628US$551.10326,993Indirect
Oct 12, 2026Common StockSale1,857US$551.92325,136Indirect
Oct 12, 2026Common StockSale558US$552.93324,578Indirect
Oct 12, 2026Common StockSale135US$554.46324,443Indirect

Source

View original at SEC

Related